(Q39946067)

15 September 2017

1 reference

title

Lithium prophylaxis: A critical review (English)

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

12 February 2023

author name string

Caffey EM Jr

2

1 reference

15 September 2017

R. F. Prien

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4606766

12 February 2023

E. M. Caffey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4606766

12 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4606766

12 February 2023

publication date

1 September 1974

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:0010440X74900352?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

https://api.elsevier.com/content/article/PII:0010440X74900352?httpAccept=text/plain

12 February 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

12 February 2023

published in

Comprehensive Psychiatry

1 reference

15 September 2017

15

1 reference

15 September 2017

257-263

1 reference

15 September 2017

5

1 reference

THE USE OF LITHIUM SALTS IN AFFECTIVE DISORDERS

15 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

THE USE OF LITHIUM IN MANIC-DEPRESSIVE PSYCHOSIS.

12 February 2023

2

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

12 February 2023

3

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Prophylactic lithium: another therapeutic myth? An examination of the evidence to date

12 February 2023

4

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

12 February 2023

Lithium

6

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

12 February 2023

9

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Prophylactic lithium in affective disorders. Controlled trial

12 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

12 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

12 February 2023

12

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness

12 February 2023

13

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Genetic history as a predictor of lithium response in manic-depressive illness

12 February 2023

14

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Clinical Factors in Lithium Carbonate Prophylaxis Failure

12 February 2023

15

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

A controlled evaluation of lithium prophylaxis in affective disorders

12 February 2023

17

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Prophylactic lithium in recurrent affective disorders

12 February 2023

18

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders

12 February 2023

19

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Lithium in the treatment of mood disorders

12 February 2023

21

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

NORMOTHYMOTICS, "MOOD-NORMALIZERS": ARE LITHIUM AND THE IMIPRAMINE DRUGS SPECIFIC FOR AFFECTIVE DISORDERS?

12 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

AMITRIPTYLINE IN DEPRESSIVE STATES: SIX-MONTH TREATMENT RESULTS.

12 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

Treatment of Depression by Drugs and Psychotherapy

12 February 2023

28

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

An evaluation of continuation therapy with tricyclic antidepressants in depressive illness

12 February 2023

29

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

The Use of Lithium in Affective Disorders: II. Prophylaxis of Depression in Chronic Recurrent Affective Disorder

12 February 2023

30

1 reference

https://api.crossref.org/works/10.1016/0010-440X(74)90035-2

12 February 2023

Identifiers

1 reference

15 September 2017

1 reference